EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genes associated with N6 ‐methyladenosine regulators provide insight into the prognosis and immune response to renal clear cell carcinoma

Guobin Fan, Dejun Wu, Huaping Chen, Zhi Wen, Linhui Liao, Shuming He, Jie Yang iD

Environmental Toxicology · 2024

DOI: 10.1002/tox.23920 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Environmental Toxicology, 2024. Verfasst von Guobin Fan und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Wanning People's Hospital, Wanning, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Kidney Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Natural Science Foundation of Hainan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

As one of the most common messenger ribonucleic acid modifications in eukaryotic organisms, N6‐methyladenosine (m6A) is involved in a wide variety of biological functions. The imbalance of m6A RNA modification may be linked to cancer and other disorders, according to a growing body of studies. Its effects on clear cell renal cell carcinoma (KIRC) have not been well discussed, though. Here, we acquired the expression patterns of 23 important regulators of m6A RNA modification and assess how they might fare in KIRC. We observed that 17 major m6A RNA modification regulatory factors had a substantial predictive influence on KIRC. Using the “ConsensusCluster” program, we defined two groupings (Cluster 1 and Cluster 2) depending on the expression of the aforementioned 17 key m6A RNA methylation regulators. The Cluster 2 has a less favorable outcome and is strongly related with a lesser immune microenvironment, according to the findings. We also developed a strong risk profile for three m6A RNA modifiers (METTL14, YTHDF1, and LRPPRC) using multivariate Cox regression analysis. According to further research, the aforementioned risk profile could serve as an independent predicting factor for KIRC, and the chemotherapy response sensitivity was analyzed between two risk groups. Moreover, to effectively forecast the future outlook of KIRC clients, we established a novel prognostic approach according to gender, age, histopathological level, clinical stage, and risk score. Finally, the function of hub gene METTL14 was validated by cell proliferation and subcutaneous graft tumor in mice. In conclusion, we discovered that m6A RNA modifiers play an important role in controlling KIRC and created a viable risk profile as a marker of prediction for KIRC clients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellKidney NeoplasmsHumansAnimalsMiceRNAImmunityTumor Microenvironment

Stichwörter der Autor:innen

N6-methyladenosine (m6A)cox regressionkidney renal clear cell carcinoma (KIRC)prognosis model

Substanzen

RNA

Autor:innen und Institutionen

  • Department of Urology, Wanning People's Hospital, Wanning, China.
  • Department of Urology, Hainan West Central Hospital, Danzhou, China.
  • Department of Urinary, The Second Affiliated Hospital of Hainan Medical University, Haikou, China.

ORCID-Profile: Jie Yang

Förderung

  • Natural Science Foundation of Hainan Province

Zitieren

APA

Fan, G., Wu, D., Chen, H., Wen, Z., Liao, L., He, S., & Yang, J. (2024). Genes associated with N6 ‐methyladenosine regulators provide insight into the prognosis and immune response to renal clear cell carcinoma. Environmental Toxicology. https://doi.org/10.1002/tox.23920

Vancouver

Fan G, Wu D, Chen H, Wen Z, Liao L, He S, et al. Genes associated with N6 ‐methyladenosine regulators provide insight into the prognosis and immune response to renal clear cell carcinoma. Environmental Toxicology. 2024. doi:10.1002/tox.23920

BibTeX
@article{Fan2024,
  author = {Fan, Guobin and Wu, Dejun and Chen, Huaping and Wen, Zhi and Liao, Linhui and He, Shuming and Yang, Jie},
  title = {Genes associated with N6 ‐methyladenosine regulators provide insight into the prognosis and immune response to renal clear cell carcinoma},
  journal = {Environmental Toxicology},
  year = {2024},
  doi = {10.1002/tox.23920}
}
Kostenlos starten →